GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Gross Margin %

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Gross Margin % : 0.00% (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Arbor Rapha Capital Bioholdings I's Gross Profit for the three months ended in Sep. 2022 was $0.00 Mil. Arbor Rapha Capital Bioholdings I's Revenue for the three months ended in Sep. 2022 was $0.00 Mil. Therefore, Arbor Rapha Capital Bioholdings I's Gross Margin % for the quarter that ended in Sep. 2022 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Arbor Rapha Capital Bioholdings I's Gross Margin % or its related term are showing as below:


ARCK's Gross Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 43.01
* Ranked among companies with meaningful Gross Margin % only.

Arbor Rapha Capital Bioholdings I had a gross margin of N/A% for the quarter that ended in Sep. 2022 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Arbor Rapha Capital Bioholdings I was 0.00% per year.


Arbor Rapha Capital Bioholdings I Gross Margin % Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I Gross Margin % Chart

Arbor Rapha Capital Bioholdings I Annual Data
Trend Dec21
Gross Margin %
-

Arbor Rapha Capital Bioholdings I Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Gross Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Arbor Rapha Capital Bioholdings I's Gross Margin %

For the Shell Companies subindustry, Arbor Rapha Capital Bioholdings I's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arbor Rapha Capital Bioholdings I's Gross Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Arbor Rapha Capital Bioholdings I's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Arbor Rapha Capital Bioholdings I's Gross Margin % falls into.



Arbor Rapha Capital Bioholdings I Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Arbor Rapha Capital Bioholdings I's Gross Margin for the fiscal year that ended in Dec. 2021 is calculated as

Gross Margin % (A: Dec. 2021 )=Gross Profit (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Arbor Rapha Capital Bioholdings I's Gross Margin for the quarter that ended in Sep. 2022 is calculated as


Gross Margin % (Q: Sep. 2022 )=Gross Profit (Q: Sep. 2022 ) / Revenue (Q: Sep. 2022 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Arbor Rapha Capital Bioholdings I  (NAS:ARCK) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Arbor Rapha Capital Bioholdings I had a gross margin of N/A% for the quarter that ended in Sep. 2022 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Arbor Rapha Capital Bioholdings I Gross Margin % Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Traded in Other Exchanges
N/A
Address
333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553
Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Ralph Mack director 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin director, officer: Chief Strategy Officer C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio officer: Chief Financial Officer C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone officer: Treasurer C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly officer: Secretary & Vice President C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker director C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin director C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines